Adaptimmune Therapeutics
(NASDAQ:ADAP)
$1.49
0.01[0.68%]
Last update: 8:57AM Get Real Time Here

GET A REPORT ON ADAP SENT RIGHT TO YOUR INBOX

Q4 2023 Earnings in 9 days from now on Wed Mar 6th, before the market open

Adaptimmune Therapeutics Stock (NASDAQ:ADAP), Earnings Estimates, EPS, and Revenue

Adaptimmune Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 6
EPS Estimate
$-0.100
Quarterly Revenue Estimate
$20.5M
Annual Revenue
(as of Sep 30)
$71.1M

Analyze the earnings history of Adaptimmune Therapeutics using advanced sorting and filters.

Date
time
ticker
Quarter
Prior EPS
Est EPS
Actual EPS
EPS Surprise
Prior Rev
Est Rev
Actual Rev
Rev Surprise
Get Alert
05/10/2024AMADAPQ1$0.00$47.60MGet Alert
03/06/2024AMADAPQ4-$0.18-$0.10$11.03M$20.47MGet Alert
11/08/2023AMADAPQ3-$0.24-$0.15-$0.18-20.00%$7.01M$10.28M$7.32M-28.80%Get Alert
08/09/2023AMADAPQ2-$0.05-$0.13-$0.127.69%$5.54M$8.78M$5.13M-41.57%Get Alert
05/12/2023AMADAPQ1-$0.05-$0.14$0.00100.00%$3.58M$4.93M$47.60M865.54%Get Alert
03/06/2023AMADAPQ4-$0.04-$0.25-$0.1828.00%$1.42M$4.12M$11.03M167.67%Get Alert
11/08/2022AMADAPQ3-$0.30-$0.24-$0.240.00%$1.20M$4.04M$7.01M73.44%Get Alert
08/04/2022AMADAPQ2-$0.24-$0.25-$0.28-12.00%$3.10M$6.00M$5.54M-7.70%Get Alert
05/09/2022AMADAPQ1-$0.04-$0.22-$0.32-45.45%$434.00K$3.29M$3.58M8.66%Get Alert
03/14/2022AMADAPQ4-$0.24$0.14-$0.25-278.57%$1.50M$96.45M$1.42M-98.53%Get Alert
11/04/2021AMADAPQ3-$0.24-$0.26-$0.30-15.38%$1.19M$1.37M$1.20M-12.19%Get Alert
08/09/2021PMADAPQ2-$0.24-$0.24-$0.240.00%$502.00K$1.36M$3.10M127.57%Get Alert
05/06/2021AMADAPQ1-$0.04-$0.25-$0.244.00%$761.00K$1.83M$434.00K-76.28%Get Alert
02/25/2021AMADAPQ4-$0.05-$0.23-$0.24-4.35%$728.00K$1.98M$1.50M-24.14%Get Alert
11/05/2020AMADAPQ3-$0.06-$0.25-$0.244.00%$237.00K$870.00K$1.19M37.13%Get Alert
08/06/2020AMADAPQ2-$0.07-$0.23-$0.24-4.35%$157.00K$930.00K$502.00K-46.02%Get Alert
05/14/2020AMADAPQ1-$0.04-$0.25-$0.0484.00%$0.00$23.29M$761.00K-96.73%Get Alert
02/27/2020AMADAPQ4$0.01-$0.32-$0.0584.38%$40.79M$1.52M$728.00K-52.11%Get Alert
11/06/2019AMADAPQ3$0.01-$0.31-$0.0680.65%$40.79M$1.48M$237.00K-83.99%Get Alert

FAQ

Q

When is Adaptimmune Therapeutics (NASDAQ:ADAP) reporting earnings?

A

Adaptimmune Therapeutics (ADAP) is scheduled to report earnings on May 10, 2024. The last reported earnings were for reported on November 8, 2023 for Q3.

Q

What were the latest earnings per share (EPS) for Adaptimmune Therapeutics (NASDAQ:ADAP)?

A

The Actual EPS was $-0.18, which missed the estimate of $-0.15.

Q

What were Adaptimmune Therapeutics’s (NASDAQ:ADAP) revenues?

A

The Actual Revenue was $7.3M, which missed the estimate of $10.3M.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch